Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Vainio M et al. | Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders. | 2004 | Acta Obstet Gynecol Scand | pmid:15548142 |
Satoh K et al. | Plasma 11-dehydrothromboxane B2: a reliable indicator of platelet hyperfunction in patients with ischemic stroke. | 1991 | Acta Neurol. Scand. | pmid:2017905 |
Hedman C et al. | Platelet function in classic migraine during attack-free periods. | 1988 | Acta Neurol. Scand. | pmid:2851913 |
Rodriguez R et al. | Effect of nimodipine on arachidonic acid metabolites after subarachnoid hemorrhage. | 1987 | Acta Neurol. Scand. | pmid:3120489 |
Cioffi FA et al. | Radioimmunoassay of thromboxane B2 in the prevention and treatment of the ischemic cerebrovascular diseases. | 1986 | Acta Neurol (Napoli) | pmid:3825614 |
Suzuki S et al. | Changes of plasma thromboxane level in subarachnoid haemorrhage. A study with 11-dehydro-TXB2 as measuring index. | 1991 | Acta Neurochir (Wien) | pmid:1799160 |
Lazarewicz JW et al. | Effects of MK-801 and ganglioside GM1 on postischemic prostanoid release and hippocampal lesion in gerbil brain. | 1994 | Acta Neurobiol Exp (Wars) | pmid:7887181 |
Galli C et al. | Modulation of prostaglandin production in tissues by dietary essential fatty acids. | 1980 | Acta Med. Scand. Suppl. | pmid:6935943 |
Mehta J and Mehta P | Significance of platelet function and thromboxane B2 levels across the human myocardial vascular bed. | 1981 | Acta Med. Scand. Suppl. | pmid:6948499 |
Vapaatalo H | Prostaglandins and coronary circulation. | 1985 | Acta Med. Scand. Suppl. | pmid:3890471 |